Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

BACKGROUND: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic therapies have demonstrated favourable outcomes in randomised controlled trials, however real-world evidence is limited. Thus, this study aimed to determine the effectiveness of targeted systemic therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkins, Robert, Fife, Kate, Hurst, Michael, Wang, Meng, Naicker, Niroshini, Nolasco, Sarah, Eisen, Tim, Matakidou, Athena, Gordon, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368711/
https://www.ncbi.nlm.nih.gov/pubmed/32680483
http://dx.doi.org/10.1186/s12885-020-07154-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368711/
https://www.ncbi.nlm.nih.gov/pubmed/32680483
http://dx.doi.org/10.1186/s12885-020-07154-z

Ejemplares similares